Who has invested in Novaremed AG?

Global Emerging Markets are named among the investors backing Novaremed AG.

Novaremed AG Funding: $66M Raised, Investors & Rounds

Novaremed AG funding overview

Novaremed AG is based in Basel, Switzerland. Novaremed AG has raised $66M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Novaremed AG runs through 2020; nothing later has been disclosed. Investors on record include Global Emerging Markets.

Novaremed AG at a glance

Total raised: $66M
Latest round date: September 2020
Headquarters: Basel, Switzerland
Notable investors: Global Emerging Markets

Frequently asked about Novaremed AG funding

How much has Novaremed AG raised?: Novaremed AG has raised $66M in total disclosed funding across the rounds on record.
Who has invested in Novaremed AG?: Global Emerging Markets are named among the investors backing Novaremed AG.
What was the latest Novaremed AG funding round?: No round stage has been disclosed for Novaremed AG.
Where is Novaremed AG based?: Novaremed AG is based in Basel, Switzerland.
When did Novaremed AG last raise?: The last disclosed Novaremed AG round closed in September 2020.

Novaremed AG totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Basel below to benchmark round size and investor mix.

Novaremed AG Funding: $66M Raised, Investors & Rounds

Novaremed AG funding overview

Novaremed AG at a glance

Frequently asked about Novaremed AG funding

Companies related to Novaremed AG (20)

Browse related funding lists (2)